Why it matters:
A loophole in the 2018 Farm Bill has inadvertently created a profitable opportunity for hemp producers. The bill legalized hemp-derived cannabinoids, leading to the emergence of various compounds, such as Delta-8 THC and THC-O, which are being used in consumables like gummies and vapes. The article emphasizes the need for consumer safety and regulation in this new market.
What they are saying:
The article explores the differences and similarities between hemp and marijuana, highlighting that they are essentially the same plant with different legal classifications. The legalization of hemp has opened up opportunities to extract and isolate various compounds, creating a wide range of minor cannabinoids.
The big picture:
The introduction of the Farm Bill loophole has created a situation where hemp-derived cannabinoids can be sold legally, leading to the emergence of new compounds and products. However, there is limited knowledge about the effects and safety of these compounds, and regulation is needed to ensure consumer protection.
What to watch:
The federal government is expected to regulate this new class of consumer products, but there is uncertainty about the specific rules and regulations that will be implemented. The DEA and FDA are working on regulations, but their official commentary has been limited. The merging of the legal hemp market and state cannabis markets will depend on the actions of federal regulators.
Take:
The article points out the confusion and uncertainty surrounding the emergence of hemp-derived cannabinoids in the market. While this presents new opportunities, it also raises concerns about consumer safety and the need for regulation. The author highlights the importance of federal regulations to ensure the safety and quality of these products.
